[Acute myocardial infarction: thrombolytic therapy in ambulance?].
Martens
F
F
Klinik für Nephrologie und internistische Intensivmedizin, Charité, Campus Virchow Klinikum, Medizinische Fakultät der Humboldt-Universität zu Berlin. frank.martens@charite.de
D000552:Ambulances; D000925:Anticoagulants / Q000008:administration & dosage*; D000075202:Contraindications; D004359:Drug Therapy, Combination; D004562:Electrocardiography; D004638:Emergency Treatment / Q000379:methods*; D005343:Fibrinolytic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D015201:Meta-Analysis as Topic; D009203:Myocardial Infarction / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D010960:Plasminogen Activators / Q000008:administration & dosage* / Q000009:adverse effects; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins / Q000008:administration & dosage; D013300:Streptokinase / Q000008:administration & dosage; D015912:Thrombolytic Therapy; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D005938:Glucocorticoids; D011994:Recombinant Proteins; C087896:reteplase; D013300:Streptokinase; D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator